Thyroid volume (ml) = (jt/6)length-width-depth (cm) In normal subjects (N = 20, 17 females, and 3 males, mean age 34.5 years), the mean thyroid volume was 7.8±2.3 ml (mean±SD). Intra-assay variation was 4.0%.
Abstract. Changes in thyroid volume during antithyroid drug therapy for Graves' disease compared with circulating thyroid parameters were evaluated. One hundred and forty-four patients with Graves' disease were treated with methimazole. Thyroid volume was measured by ultrasonography (thyroid volume = \ g=P\abc/6, where a is length, b width, and c depth). Serum (4) (5) (6) (7) (8) .
In the present study, we (Fig. 4) . On the other hand, a positive correlation was found between Tg and TBII (p<0.01, Fig. 5 ).
Eleven patients were followed during one year of treatment with the antithyroid drug. After one year of therapy, the mean thyroid volume had de¬ creased significantly (p<0.01, Fig. 6 ). The mean serum TBII level had decreased significantly (p<0.01, Fig. 6 (Fig. 2 ), but not with TS-ab (Fig. 3) . It is possible that our assay system of TS-ab was more sensitive than that of other investigators. Correlation between serum thyroid-binding inhibitory immunoglobulins (TBII) (Fig. 1) . In addition, serum Tg correlated significantly with serum TBII (Fig. 5) . Patients (10, 20) .
The present study demonstrated that most of the patients with Graves' disease obtained a reduction of goitre size during antithyroid drug therapy, as¬ sociated with decreasing serum TBII levels (Fig. 6) (Fig. 7) , suggesting that in¬ creasing levels of TSH had a thyroid growth-stim¬ ulating effect.
In conclusion, the thyroid volume decreased during methimazole treatment with decreasing serum TBII levels. In 
